NEQCA Accountable Care, Inc is NEQCA’s network-wide Medicare Accountable Care Organization (ACO).  An ACO is a group of providers who voluntarily agree to be accountable for the quality and cost of care of a defined group of Medicare fee-for-service beneficiaries. 

For general questions or additional information about Accountable Care Organizations, please visit www.medicare.gov/acos.html or call 1-800-MEDICARE (1-800-633-4227) TTY users should call 1-877-486-2048. 

If you are a NEQCA provider, and your practice is interested in participating in the ACO, please contact Chantal Buchanan, ACO Director of Operations.

ACO Name and Location

NEQCA Accountable Care, Inc. 

325 Wood Road, Suite 210

Braintree, Massachusetts 02184

ACO Primary Contact 

Primary Contact Name

Chantal Buchanan

Primary Contact Phone Number

781-356-3336

Primary Contact Email Address

cbuchanan@neqca.org

Organizational Information

ACO Governing Body                   

  • Julie Tishler, MD - Medical Group, Inc.
  • Matt Larkin - Pratt Medical Group, Inc.
  • Ahmed Basheer, MD - Pondville Medical Associates, Inc.
  • Ron Keating – Medicare Beneficiary
  • Mark Collins, MD - Osterville Healthcare, PC
  • Mark Singh, MD – Blue Hills Medical Associates
  • Andrew Romanowsky, MD - Mark Romanowsky, MD, PC
  • Dhiren Sutaria, MD- Woodland Internists, PC
  • Meg Costello – ACO Executive Director
  • Timothy Tierney - Main Street Family Practice, PC
  • Eric Silverman, MD - Pulmonary Associates of Metrowest

Key ACO Clincal and Administrative Leadership

Margaret Costello

ACO Executive

Jatin Dave

Medical Director

Cara Merski

Compliance Officer

Liz Savaria-Porter

Quality Assurance/Improvement Officer

Associated Committees and Committee Leadership

Committee Name

Committee Leader Name and Position

ACO Funds Flow Committee

Mark Singh, MD, Participant and ACO Trustee

ACO Finance Committee

Matt Larkin, Participant and ACO Trustee

ACO Quality Committee

Jatin Dave, MD, ACO Medical Director and Chief Medical Officer

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Performance Year 2018: 

Shared Savings Distribution

  • Performance Year 2018
      • Proportion invested in infrastructure: 
      • Proportion invested in redesigned care processes/resources: 
      • Proportion of distribution to ACO participants: 

Quality Performance Results 

2018 Quality Performance Results: 

ACO#

Measure Name

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

ACO-2

CAHPS: How Well Your Providers Communicate

ACO-3

CAHPS: Patients' Rating of Provider

ACO-4

CAHPS: Access to Specialists

ACO-5

CAHPS: Health Promotion and Education

ACO-6

CAHPS: Shared Decision Making

ACO-7

CAHPS: Health Status/Functional Status

ACO-34

CAHPS: Stewardship of Patient Resources

ACO-8

Risk-Standardized, All Condition Readmission

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

ACO-9

Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )

ACO-39

Documentation of Current Medications in the Medical Record

ACO-13

Falls: Screening for Future Fall Risk

ACO-14

Preventive Care and Screening: Influenza Immunization

ACO-15

Pneumonia Vaccination Status for Older Adults

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

ACO-19

Colorectal Cancer Screening

ACO-20

Breast Cancer Screening

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

ACO-41

Diabetes: Eye Exam

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

  • 2015 Performance Summary Statistics

    Performance Measure

    ACO Performance Rate

    Mean Performance Rate for All ACOs

    Risk Standardized, All Condition Readmissions (ACO-8)

    ASC Admissions: COPD or Asthma in Older Adults (ACO-9)

    ASC Admission: Heart Failure (ACO-10)

    Percent of Primary Care Providers who Qualified for EHR Incentive Payment (ACO- 11)